All Industries

Top Biotech Companies

5,081 Biotech companies, sorted by total funding raised.

Denali TherapeuticsIPO

Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...

South San Francisco, United States201–500Biotech, Healthcare
Venture Round·$1.3B·Dec 2025
Abogen Biosciences

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021
Neuralink

Neuralink is building a brain-computer interface for medical needs and greater human potential.

Fremont, United States201–500Biotech, Healthcare
Series E·$1.2B·Jun 2025
BioNTechIPO

German biotech company developing mRNA-based immunotherapies and vaccines.

Mainz, Germany5001–10000Biotech, Healthcare
Series B·$1.2B·Jul 2019
ModernaIPO

Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeli...

Cambridge, United States1001–5000Biotech, Healthcare
Grant·$1.1B·Jan 2018
argenx SEIPO

Global biopharmaceutical company developing antibody-based therapies for severe autoimmune diseas...

Amsterdam, Netherlands501–1000Biotech, Healthcare
Growth Equity·$1.1B·Jul 2023
ElevateBio

ElevateBio is a biotech company powering transformative cell and gene therapies through integrate...

Cambridge, United States201–500Biotech
Series D·$1.1B·May 2023
PB
Pacific Biosciences of CaliforniaIPO

PacBio provides highly accurate long-read DNA sequencing systems for genomics, transcriptomics, a...

Menlo Park, United States501–1000Biotech, Manufacturing
Corporate Round·$1.1B·Feb 2021
Ultima Genomics

Novel DNA sequencing architecture to scale the ultra low cost whole genome

Fremont, United States201–500Artificial Intelligence, Healthcare
Series E·$1.1B·Jun 2022
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series D·$1.1B·Feb 2025
GeneDxIPO

Genetic testing company specializing in rare disease diagnostics through whole exome and genome s...

Stamford501–1000Biotech, Healthcare
Corporate Round·$1.0B·Jan 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
Kailera TherapeuticsIPO

Clinical-stage biotech developing next-generation GLP-1/GIP dual agonist therapies for obesity

Waltham, United States51–200Biotech, Healthcare
Series B·$1.0B·Oct 2025
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series C·$955.0M·Sep 2024
Cellares

Cell therapy manufacturing company building automated factories to accelerate cell therapy produc...

South San Francisco, United States51–200Biotech, Healthcare
Series D·$939.0M·Jun 2026
ZymergenClosed

Zymergen was a biomanufacturing company using AI and machine learning to engineer microbes for pr...

Emeryville, United States501–1000Advanced Materials, Artificial Intelligence
Series D·$928.1M·Sep 2020
Apeel Sciences

Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...

GOLETA, United States201–500Agtech, Food Tech
Series F·$912.9M·Jul 2025
Pacific Biosciences

Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...

Menlo Park, United States501–1000Biotech, Genomics
Convertible·$900.0M·Feb 2021
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture Round·$884.0M·Jul 2025
Candid TherapeuticsClosed

Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...

San Diego, United States11–50Biotech, Therapeutics
Venture Round·$875.0M·Mar 2026
Brii BiosciencesIPO

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China a...

San Francisco Bay Area, United States51–200Biotech, Healthcare
Venture Round·$865.0M·May 2025
NewLimit

Longevity biotech developing epigenetic reprogramming medicines to extend human healthspan and re...

South San Francisco, United States11–50Biotech, Healthcare
Venture Round·$865.0M·Jun 2026
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series E·$853.3M·Jun 2026
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Life Sciences, Biosimulation
Private Equity·$850.0M·Jan 2017
Ocular TherapeutixIPO

Biopharmaceutical company developing sustained-release hydrogel therapies targeting retinal disea...

Bedford, United States201–500Biotech, Healthcare
Private Equity·$836.7M·Sep 2025